Before you get in touch.

Ask who owns the formula and when that gets agreed. Ask whether they formulate or resell a stock base. Ask what happens if the formula fails stability after handoff. Ask whether they take commissions from suppliers or manufacturers they recommend. The answers to those four tell you most of what you need to know about how the engagement will actually go.

Ask them to describe what happens in the first three weeks. A studio will talk about your brief, your competitive set and bench work. A private label supplier will move quickly to a catalogue and a minimum order quantity. Neither is wrong — they are different products — but you should know which one you are buying.

If a stock formula genuinely does what you need, a manufacturer alone can be sufficient and cheaper. You need a chemist when your positioning depends on something the available bases cannot support, when an existing product is failing, or when you need the formula to be an asset your brand owns.

Reluctance to put ownership in writing. A quote given before anyone has asked about your claims or constraints. Unwillingness to say a request is not achievable. And referral recommendations from someone who is being paid for the referral — that is not necessarily disqualifying, but you should know it is happening.

Almost always one product first, unless you have proven demand across a line. Developing one hero product properly gives you something defensible to talk about and something real in a pitch deck. Ranges built before there is demand tend to be reformulated later, at scale, under pressure — which costs more than doing it once.

No — and that's the difference. Private label means putting your name on an existing stock formula that dozens of other brands also sell. SkinChemy develops an original formula to your brief, which means the product is yours, differentiated, and defensible.

SkinChemy is a formulation studio, not a factory. I develop and prove the formula at bench scale, then hand off complete documentation and scale-up guidance to your contract manufacturer. If you don't have one yet, I can help you evaluate options and ask the right questions.

It depends on the category and how many rounds of refinement you want. A single straightforward product moves faster than a coordinated multi-SKU range. We'll set a realistic timeline in the discovery call — before any money changes hands.

Pricing is scoped per project, based on category complexity, the number of SKUs, and how much development strategy you need. Share your budget range in the form and you'll get an honest answer on fit before we spend time on a call.

Ownership and confidentiality terms are agreed in writing at the start of the engagement. Bring your NDA, or we can work from a standard one — either way, it gets settled before development begins.

Yes — reach out anyway. Early-stage brands are often better served by a focused consultation or a single hero product than a full range, and it's cheaper to get the strategy right before you've committed to a manufacturer.

Private label means putting your name on an existing stock formula that other brands also sell. A custom formula is developed to your brief and belongs to your brand — differentiated, defensible, and portable between manufacturers.

No, and most brands should not. Developing one hero product properly — the one the brand is actually known for — and filling out the range more conventionally until volume justifies more is usually the better commercial decision.

Yes. Strategy is a standalone engagement, and for early-stage brands it is often the more valuable one — it is considerably cheaper to get the plan right than to develop the wrong product well.

Yes. An honest read on whether a concept has a commercial path is the point of the exercise, and it is the cheapest bad news you will ever receive.

It makes the work faster and cheaper, but it is not always essential — the failure mode itself often indicates the cause. If you do not own the formula because it came from a private label supplier, that constraint is worth discussing early.

No, though it is more expensive than fixing it at bench scale. Committed inventory and in-market customers both constrain what can change, so the sooner the diagnosis happens the more options remain.

Yes. Documentation and scale-up preparation is available as a standalone engagement for a formula developed elsewhere, provided you have the right to use it.

I can help you evaluate candidates and ask the right questions. The choice stays yours — I do not take referral commissions, which is the arrangement that keeps that advice worth having.

Terms are month to month and scoped to your expected volume. It is not a long-term lock-in, because a retainer nobody is using should be cancelled rather than renewed.

Bench development is scoped separately. Retainer time covers judgement and review rather than lab work, which keeps both easier to price honestly.

Yes, and the idea that they cannot be combined is largely a persistent myth built on conditions that do not reflect a well-built formula. The real question is whether the combination is stable in your specific system and at your specific pH, which is a formulation question rather than a rule.

Mostly rheology and afterfeel rather than ingredient cost. Cushion on application, a clean absorption curve and no residual tack read as premium. A formula can carry costly actives and still feel cheap if the base was not designed for it.

No. "Sulfate-free" describes what is absent, not how the system behaves. A well-built formula containing a sulfate can be gentler than a poorly built one without. The relevant question is the whole surfactant system, not one ingredient class.

Poorly built ones largely are. A mist that does something — delivers humectants, supports a hydration claim, holds up under makeup — is a real formulation, and the difference is obvious to customers within a few uses.